Venrock Healthcare Capital Partners III LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Venrock Healthcare Capital Partners III LP
CIK #0001738048
EDGAR Form CIK 2011 - 2026
3 [0001738048]
4 [0001738048]
D [0001738048]
SC 13D [0001738048]
SC 13G [0001738048]
Form 13D/13G Filer Form 13D/13G Subject Filed
Venrock Healthcare Capital Partners III LP Relmada Therapeutics Inc [2026-06-09]
Venrock Healthcare Capital Partners III LP Achieve Life Sciences Inc [2026-04-24]
Venrock Healthcare Capital Partners III LP Korro Bio Inc [2026-03-17]
Venrock Healthcare Capital Partners III LP Galecto Inc [2026-02-17]
Venrock Healthcare Capital Partners III LP Adlai Nortye Ltd [2026-02-11]
Venrock Healthcare Capital Partners III LP Century Therapeutics Inc [2026-01-16]
Venrock Healthcare Capital Partners III LP Cybin Inc [2025-11-07]
Venrock Healthcare Capital Partners III LP Savara Inc [2025-07-08]
Venrock Healthcare Capital Partners III LP Glycomimetics Inc [2025-06-23]
Venrock Healthcare Capital Partners III LP Oric Pharmaceuticals Inc [2025-05-30]
View All
Form 3/4/5 Subject 2011 - 2026
Shah Nimish P
VHCP Management EG LLC
VHCP Management III LLC
Venrock Healthcare Capital Partners EG LP
Koh Bong Y
Venrock Healthcare Capital Partners III LP
VHCP Co-Investment Holdings III LLC
KalVista Pharmaceuticals Inc
Oruka Therapeutics Inc
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
Venrock Healthcare Capital Partners II LP
Tricida Inc
Vistagen Therapeutics Inc
Pharmathene Inc
Cogent Biosciences Inc
Constellation Pharmaceuticals Inc
Venrock Associates IV L P
Bellerophon Therapeutics LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 3,183 $19.12 60,859
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 21,386 $17.76 379,815
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-26 Sell 15,417 $18.82 290,148
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-25 Sell 174,485 $16.95 2,957,521
KalVista Pharmaceuticals Inc KALV
Common Stock
2026-03-25 Sell 160 $17.53 2,805
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-04-09 Buy 25,000 $9.42 235,500
Oruka Therapeutics Inc ORKA
Common Stock
2025-02-14 Buy 88,794 $11.44 1,015,803
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-13 Buy 61,700 $9.33 575,661
Oruka Therapeutics Inc ORKA
Common Stock
2025-02-13 Buy 14,950 $11.63 173,868
Oruka Therapeutics Inc ORKA
Common Stock
2025-02-12 Buy 8,971 $11.86 106,396
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-12 Buy 100,000 $9.23 923,000
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-11 Buy 26,703 $9.18 245,134
Oruka Therapeutics Inc ORKA
Common Stock
2025-02-11 Buy 9,593 $10.95 105,043
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-10 Buy 4,137 $9.14 37,812
Oruka Therapeutics Inc ORKA
Common Stock
2025-02-10 Buy 574 $10.90 6,257
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-07 Buy 73,649 $9.29 684,199
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-02-03 Buy 14,562 $9.22 134,262
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-01-31 Buy 11,754 $8.89 104,493
KalVista Pharmaceuticals Inc KALV
Common Stock
2025-01-30 Buy 43,707 $8.76 382,873
KalVista Pharmaceuticals Inc KALV
Pre-Funded Warrants (Right to Buy) · derivative
2024-02-20 Buy 655,738 $15.25 10,000,004
showing 20 of 120 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com